Yüklüyor......
Chemotherapy Combinations With Monoclonal Antibodies in Non-Hodgkin’s Lymphoma
Although the use of monoclonal antibodies as single agents has had a tremendous impact on the care of patients with non-Hodgkin’s lymphoma (NHL), the greatest benefit has been generated by the addition of monoclonal antibodies to conventional cytotoxic chemotherapy. Rituximab is the monoclonal antib...
Kaydedildi:
| Yazar: | |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2008
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2919066/ https://ncbi.nlm.nih.gov/pubmed/18381103 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.seminhematol.2008.02.003 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|